SMITH-FARRELL JOANNE (Chief Business Officer) sold 6.1% of their position (1.33K shares) of BLUEBIRD BIO, INC. on the open market
Open‑market sale worth $59.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/8/2021ACC: 0001562180-21-000264
Officer· Chief Business Officer
Since Jan 2020
-1.33K
Net shares
Net seller
$59.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.33K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−42.00
Price / share
$44.95
Trade value
$1.89K
% of position
0.2%
1/5/2021
21.94K→21.90K
Common Stock
Direct
Shares
−749.00
Price / share
$44.76
Trade value
$33.52K
% of position
3.4%
1/6/2021
21.90K→21.15K
Common Stock
Direct
Shares
−538.00
Price / share
$45.46
Trade value
$24.46K
% of position
2.5%
1/6/2021
21.15K→20.61K
Total
Net shares
−1.33K
Net value
-$59.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2021 | S · Sale | −42.00 | $44.95 | $1.89K | 0.2% | 21.94K | 21.90K |
| Common Stock Direct | 1/6/2021 | S · Sale | −749.00 | $44.76 | $33.52K | 3.4% | 21.90K | 21.15K |
| Common Stock Direct | 1/6/2021 | S · Sale | −538.00 | $45.46 | $24.46K | 2.5% | 21.15K | 20.61K |
| Total | −1.33K | -$59.87K | ||||||
Derivative Transactions0
No derivative transactions reported